Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area

Daniel Huff; Neil M. Ampel; Janis E. Blair

doi:10.1007/s11046-022-00629-6

Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area

Daniel Huff, Neil M. Ampel, Janis E. Blair

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

At a single medical center, we identified 60 cases of coccidioidomycosis that were coincident with COVID-19 infection. Among these, seven patients developed new or clinically progressive coccidioidomycosis. Receipt of dexamethasone for COVID-19 infection was the only significant risk factor for the progression or development of clinically active coccidioidomycosis in this cohort. All patients survived and none developed disseminated coccidioidomycosis.

Original language	English (US)
Pages (from-to)	199-204
Number of pages	6
Journal	Mycopathologia
Volume	187
Issue number	2-3
DOIs	https://doi.org/10.1007/s11046-022-00629-6
State	Published - Jun 2022
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature B.V.

Keywords

Coccidioidomycosis
COVID-19
Fungal infections
SARS-CoV-2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1007/s11046-022-00629-6

OpenUrl availability

Full text

Cite this

@article{4ded7533317a492886fa66cfa1cf6a91,

title = "Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area",

abstract = "At a single medical center, we identified 60 cases of coccidioidomycosis that were coincident with COVID-19 infection. Among these, seven patients developed new or clinically progressive coccidioidomycosis. Receipt of dexamethasone for COVID-19 infection was the only significant risk factor for the progression or development of clinically active coccidioidomycosis in this cohort. All patients survived and none developed disseminated coccidioidomycosis.",

keywords = "Coccidioidomycosis, COVID-19, Fungal infections, SARS-CoV-2",

author = "Daniel Huff and Ampel, {Neil M.} and Blair, {Janis E.}",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Nature B.V.",

year = "2022",

month = jun,

doi = "10.1007/s11046-022-00629-6",

language = "English (US)",

volume = "187",

pages = "199--204",

journal = "Mycopathologia",

issn = "0301-486X",

publisher = "Springer Netherlands",

number = "2-3",

}

TY - JOUR

T1 - Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area

AU - Huff, Daniel

AU - Ampel, Neil M.

AU - Blair, Janis E.

PY - 2022/6

Y1 - 2022/6

N2 - At a single medical center, we identified 60 cases of coccidioidomycosis that were coincident with COVID-19 infection. Among these, seven patients developed new or clinically progressive coccidioidomycosis. Receipt of dexamethasone for COVID-19 infection was the only significant risk factor for the progression or development of clinically active coccidioidomycosis in this cohort. All patients survived and none developed disseminated coccidioidomycosis.

AB - At a single medical center, we identified 60 cases of coccidioidomycosis that were coincident with COVID-19 infection. Among these, seven patients developed new or clinically progressive coccidioidomycosis. Receipt of dexamethasone for COVID-19 infection was the only significant risk factor for the progression or development of clinically active coccidioidomycosis in this cohort. All patients survived and none developed disseminated coccidioidomycosis.

KW - Coccidioidomycosis

KW - COVID-19

KW - Fungal infections

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85128226785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128226785&partnerID=8YFLogxK

U2 - 10.1007/s11046-022-00629-6

DO - 10.1007/s11046-022-00629-6

M3 - Article

C2 - 35428955

AN - SCOPUS:85128226785

SN - 0301-486X

VL - 187

SP - 199

EP - 204

JO - Mycopathologia

JF - Mycopathologia

IS - 2-3

ER -

Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this